| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8683724 | Epilepsy & Behavior | 2018 | 6 Pages |
Abstract
A substantial proportion of newly treated US patients with epilepsy are underserved regarding newer AED use with Mississippi and Washington, DC having the highest proportion of phenytoin use relative to newer AED use. Understanding the socioeconomic and demographic barriers for these observations is essential in planning interventions to improve the quality of life and care for patients with epilepsy, including newly treated patients. These data provide a baseline to target educational and clinical interventions for improving the quality of US epilepsy care.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Joseph I. Sirven, Patricia O. Shafer, Linda Kalilani, Imane Wild, Jesse Fishman, Steve Owens,